All News

Schwartz's background as a physician with plenty of government service experience will likely be popular among…

RFK Jr. focused on President Trump's health care agenda and largely avoided vaccines.…

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hor…

This data note reviews our recent polling data that finds that many Americans struggle to afford many aspects …

If you asked me a year ago to break down the different areas of healthcare AI we’re covering, it might’ve look…

As the prices paid for priority review vouchers (PRVs) have crept up over the past year — the last two have so…

The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufa…

In this edition of STAT Health Tech: CMS may change breakthrough device payments, Zealthy's legal troubles, an…

Johnson & Johnson leaders have laid out a plan to reach record revenue this year while opening the door to…

RFK Jr.'s testimony to Congress, broader access to peptides, and more health news from Morning Rounds…

Terremoto says that its AKT1 blockers can overcome toxicity challenges associated with PI3K/AKT inhibitors thr…

Nucleai has partnered with Sirona Dx to provide an integrated spatial proteomics solution for pharmaceutical a…

Boehringer Ingelheim and Zai Lab have entered into a clinical collaboration to investigate a dual DLL3-targeti…

Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after…

Abridge is partnering with top medical journals to bring in research for doctors to refer to during visits, pi…

The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in Apr…

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additiona…

Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimen…

Two new startups have begun testing their in vivo CAR-T therapies for autoimmune disease in people. China-base…

Inside Biogen's $5.6B buyout: CEO Chris Viehbacher has carried on with diversifying Biogen's business beyond i…

The FDA's guidance emphasises the potential of NGS methods to mitigate safety risks associated with therapies …

The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scie…

This brief highlights lessons from “Medicaid unwinding" that could help inform work requirement implementation…